There is limited clinical data on the safety of single-dose administration of CIALIS in patients with severe hepatic insufficiency (Child-Pugh Class C).
CIALIS’ e üksikannuse ohutuse kohta on vähe kliinilisi andmeid raske maksapuudulikkusega (Child - Pugh klass C) patsientidel.